Rituxan (rituximab) - Roche
Non-Lupus Full-House Nephropathy in Kidney Transplant Recipients (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1168; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Patient was given rituximab four doses 500mg weekly...Said et al retrospectically analysed 24 allograft biopsies with intense C1q deposition and concluded that it is a morphological pattern with no clinical significance. however in our all 3 patients serum creatinine and proteinuria improved markedly." 
Clinical • Glomerulonephritis • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Transplantation
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4558327
 
Devendra Kumar Agarwal
 
Oct 2, 2026
 
Prev Next